WO2001023553A8 - Metastasis-associated antigen c4.4a - Google Patents

Metastasis-associated antigen c4.4a

Info

Publication number
WO2001023553A8
WO2001023553A8 PCT/EP2000/009567 EP0009567W WO0123553A8 WO 2001023553 A8 WO2001023553 A8 WO 2001023553A8 EP 0009567 W EP0009567 W EP 0009567W WO 0123553 A8 WO0123553 A8 WO 0123553A8
Authority
WO
WIPO (PCT)
Prior art keywords
associated antigen
metastasis
cells
metastasizing
relates
Prior art date
Application number
PCT/EP2000/009567
Other languages
French (fr)
Other versions
WO2001023553A2 (en
WO2001023553A9 (en
WO2001023553A3 (en
Inventor
Margot Zoeller
Marc Roesel
Jens Wuerfel
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Priority to EP00972663A priority Critical patent/EP1220919A2/en
Publication of WO2001023553A2 publication Critical patent/WO2001023553A2/en
Publication of WO2001023553A3 publication Critical patent/WO2001023553A3/en
Publication of WO2001023553A9 publication Critical patent/WO2001023553A9/en
Publication of WO2001023553A8 publication Critical patent/WO2001023553A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to gene expression in normal cells and cells of metastasizing tumors and particularly to a novel metastasis-associated antigen, C4.4A, and isolated nucleic acid molecules encoding C4.4A. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating proliferative disorders associated with a metastasizing tumor.
PCT/EP2000/009567 1999-09-29 2000-09-29 Metastasis-associated antigen c4.4a WO2001023553A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP00972663A EP1220919A2 (en) 1999-09-29 2000-09-29 Metastasis-associated antigen c4.4a

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40778499A 1999-09-29 1999-09-29
US09/407,784 1999-09-29

Publications (4)

Publication Number Publication Date
WO2001023553A2 WO2001023553A2 (en) 2001-04-05
WO2001023553A3 WO2001023553A3 (en) 2001-11-08
WO2001023553A9 WO2001023553A9 (en) 2001-12-06
WO2001023553A8 true WO2001023553A8 (en) 2002-01-03

Family

ID=23613517

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009567 WO2001023553A2 (en) 1999-09-29 2000-09-29 Metastasis-associated antigen c4.4a

Country Status (2)

Country Link
EP (1) EP1220919A2 (en)
WO (1) WO2001023553A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
DK2510012T3 (en) * 2009-12-09 2017-07-31 Bayer Pharma AG ANTIBODIES AGAINST C4.4A AND APPLICATIONS THEREOF
WO2011158883A1 (en) * 2010-06-15 2011-12-22 国立大学法人大阪大学 Antibody capable of determination of cancer prognosis, and cancer prognosis determination method
TWI636793B (en) 2011-04-21 2018-10-01 西雅圖遺傳學公司 New binder-drug conjugates (adcs) and use thereof
AU2016249839B2 (en) 2015-04-17 2021-09-09 Ventana Medical Systems, Inc. Antibodies, compositions, and immunohistochemistry methods for detecting C4.4a

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053758A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same
EP1021531A2 (en) * 1997-10-08 2000-07-26 Sagami Chemical Research Center HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
EP1210418B1 (en) * 1999-06-02 2010-08-18 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1185648T3 (en) * 1999-06-02 2007-07-30 Genentech Inc Methods and compositions for inhibiting neoplastic cell growth

Also Published As

Publication number Publication date
EP1220919A2 (en) 2002-07-10
WO2001023553A2 (en) 2001-04-05
WO2001023553A9 (en) 2001-12-06
WO2001023553A3 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
WO2002010382A3 (en) Trp8, trp9 and trp10, markers for cancer
WO1998031818A3 (en) Tace-like and matrilysin-like polypeptides
WO2001058915A8 (en) Human g-protein chemokine receptor (ccr5) hdgnr10
WO2001018172A3 (en) Fibroblast growth factor-like polypeptides
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
WO2001036432A3 (en) 18 human secreted proteins
WO2001032910A3 (en) 27 human secreted proteins
DE69935220D1 (en) HUMAN TUMOR-DERIVED POLYPEPTIDEHORMONE PHOSPHATONIN
WO2001012776A3 (en) 18 human secreted proteins
WO2000012702A3 (en) Human genes differentially expressed in colorectal cancer
WO2001034768A3 (en) 15 human secreted proteins
WO2002078526A3 (en) Cancer-testis antigens
WO2000052136A3 (en) Human glycosylation enzymes
WO2002086071A3 (en) Cancer-testis antigens
WO2000043493A8 (en) Metalloproteinase adam 22
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2000077026A8 (en) 49 human secreted proteins
WO2001023553A3 (en) Metastasis-associated antigen c4.4a
WO2000063230A3 (en) 49 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
WO2001012775A3 (en) 25 human secreted proteins
MY127669A (en) Polypeptide hormone phosphatonin
WO2000061624A8 (en) 48 human secreted proteins
WO2000043495A3 (en) 33 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: C2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: INDICATIONS RELATING TO A DEPOSITED MICROORGANISM, ADDED (4 PAGES)

AK Designated states

Kind code of ref document: C1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 14/2001 UNDER "PUBLISHED", ADD "WITH (AN) INDICATION(S) IN RELATION TO DEPOSITED BIOLOGICAL MATERIAL FURNISHED UNDER RULE 13BIS SEPARATELY FROM THE DESCRIPTION"

WWE Wipo information: entry into national phase

Ref document number: 2000972663

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000972663

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000972663

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP